196
Views
15
CrossRef citations to date
0
Altmetric
Original Research

The French addictovigilance network clinical assessment: Z-drugs, true false twins

, , , , &
Pages 1063-1069 | Received 14 Apr 2017, Accepted 20 Jun 2017, Published online: 28 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Marion Istvan, Morgane Rousselet, Edouard-Jules Laforgue, Marylène Guerlais, Marie Gérardin, Pascale Jolliet, Fanny Feuillet & Caroline Victorri-Vigneau. (2022) Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database. Expert Opinion on Drug Safety 21:9, pages 1225-1234.
Read now
Fabio Lugoboni, Antonio Mirijello, Laura Morbioli, Marco Faccini, Rebecca Casari, Salvatore De Cosmo, Antonio Gasbarrini & Giovanni Addolorato. (2019) Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients. Expert Opinion on Drug Safety 18:8, pages 753-758.
Read now

Articles from other publishers (13)

Aurélie Aquizerate, Edouard-Jules Laforgue, Marion Istvan, Morgane Rousselet, Marie Gerardin, Emilie Jouanjus, Frédéric Libert, Anne-Sylvie Caous, Leila Chaouachi, Cécile Chevallier, Amélie Daveluy, Céline Eiden, Bernard Fauconneau, Christine Fournier-Choma, Valérie Gibaja, Clémence Lacroix, Maryse Lapeyre-Mestre, Reynald Le Boisselier, Bruno Revol, Marylène Guerlais & Caroline Victorri-Vigneau. (2023) French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change. European Journal of Public Health 33:2, pages 169-175.
Crossref
Morgane Rousselet, Marie Gerardin, Marion Istvan, Lou Madieta, Fanny Feuillet & Caroline Victorri-Vigneau. (2022) PROMESS : comparaison des profils de dépendance dans les notifications spontanées. Exemple de la buprénorphine et de la méthadone. Therapies 77:6, pages 776.
Crossref
Daniela F. Curado, Viviam V. de Barros, Ana R. Noto & Emérita S. Opaleye. (2022) Dependence on hypnotics: a comparative study between chronic users of benzodiazepines and Z-drugs. Brazilian Journal of Psychiatry 44:3, pages 248-256.
Crossref
Edouard-Jules Laforgue, Marion Istvan, Benoit Schreck, Marie Mainguy, Pascale Jolliet, Marie Grall-Bronnec & Caroline Victorri-Vigneau. (2022) Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior. Journal of Clinical Medicine 11:8, pages 2176.
Crossref
Vincenz Scharner, Lukas Hasieber, Andreas Sönnichsen & Eva Mann. (2022) Efficacy and safety of Z-substances in the management of insomnia in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing. BMC Geriatrics 22:1.
Crossref
Fabio Lugoboni, Rebecca Casari, Francesca Fusina & Lorenzo Zamboni. (2021) Zolpidem: A masked hero. A reply to ZORRO study. British Journal of Clinical Pharmacology 87:10, pages 4040-4041.
Crossref
Catherine Roch, Giorgio Bergamini, Michel A. Steiner & Martine Clozel. (2021) Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia. Psychopharmacology 238:10, pages 2693-2708.
Crossref
Marion Istvan, Pascal Caillet, Morgane Rousselet, Marylène Guerlais, Edouard‐Jules Laforgue, Marie Gérardin, Pascale Jolliet, Fanny Feuillet & Caroline Victorri‐Vigneau. (2021) Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study. British Journal of Clinical Pharmacology 87:8, pages 3310-3319.
Crossref
Laura Orsolini, Stefania Chiappini, Paolo Grandinetti, Angelo Bruschi, Roberta Testa, Alessandra Provenzano, Domenico De Berardis & Umberto Volpe. (2021) ‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse. Clinical Psychopharmacology and Neuroscience 19:2, pages 367-387.
Crossref
J. Touchard, P. Sabatier, G. Airagnes, S. Berdot & B. Sabatier. (2019) Consequences of the new zolpidem prescription regulations: a cohort study from the French national healthcare database. European Journal of Clinical Pharmacology 76:1, pages 89-95.
Crossref
Sven Buth, Rüdiger Holzbach, Marcus-Sebastian Martens, Eike Neumann-Runde, Ommo Meiners & Uwe Verthein. (2019) Problematic Medication With Benzodiazepines, “Z-drugs”, and Opioid Analgesics. Deutsches Ärzteblatt international.
Crossref
Marie Gérardin, Morgane Rousselet, Pascal Caillet, Marie Grall-Bronnec, Pierre Loué, Pascale Jolliet & C Victorri-Vigneau. (2019) French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol. BMJ Open 9:6, pages e027443.
Crossref
E. Chambost & M. Chappuy. (2018) Impact de la nouvelle réglementation du zolpidem – enquête dans la circonscription départementale du Rhône. Le Pharmacien Hospitalier et Clinicien 53:4, pages 288-300.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.